Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

SRp55 Activators

SRp55 activators refer to a specific class of chemical compounds that interact with and modulate the activity of the SRp55 protein. SRp55, also known as Serine/arginine-rich splicing factor 6 (SRSF6), is a crucial component of the spliceosome, a complex molecular machine responsible for pre-mRNA splicing in eukaryotic cells. Pre-mRNA splicing is a fundamental process in gene expression, where introns are removed, and exons are joined together to create mature mRNA molecules. The correct splicing of pre-mRNA is essential for generating functional and diverse protein products from a single gene. SRp55 activators are characterized by their ability to influence the splicing activity of SRp55. These compounds may work by binding to SRp55 and modifying its function, affecting its interactions with pre-mRNA and other splicing factors. The precise mechanisms by which SRp55 activators influence splicing are an active area of research, and they may have implications for the regulation of alternative splicing, a process that generates multiple mRNA isoforms from a single gene. Alternative splicing plays a crucial role in expanding the proteome's diversity and can have profound effects on cellular function and phenotype.

Researchers study SRp55 activators to gain insights into the intricate process of pre-mRNA splicing and its regulation. Understanding the molecular mechanisms behind splicing factor activation can shed light on how cells control gene expression and generate functional diversity in proteins. Additionally, these compounds can serve as valuable tools for manipulating splicing events in the laboratory, enabling scientists to investigate the functional consequences of altered splicing patterns in various cellular and developmental contexts. The study of SRp55 activators contributes to our broader understanding of gene regulation and the intricate machinery that governs the expression of genetic information.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

This short-chain fatty acid, often used in epigenetic studies, can influence alternative splicing by modifying chromatin structure, potentially affecting SRp55.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, 5-Azacytidine, can alter gene expression and potentially splicing factor activity, including SRp55.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

As a histone deacetylase inhibitor, Trichostatin A can modify chromatin architecture, indirectly impacting splicing factor functions.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid, involved in gene transcription regulation, may have downstream effects on splicing factors, including SRp55.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Cholecalciferol, through its receptor-mediated gene regulation, might influence splicing factors indirectly.

Spliceostatin A

391611-36-2sc-507481
1 mg
$1800.00
(0)

While primarily an inhibitor, Spliceostatin A's influence on general splicing machinery could indirectly affect SRp55's activity.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

This compound, known for affecting splicing, may have an indirect effect on SRp55 through broad splicing factor modulation.

Ispinesib

336113-53-2sc-364747
10 mg
$505.00
(0)

While primarily a kinesin inhibitor, Ispinesib can affect cellular processes that indirectly modify splicing factor activity, including SRp55.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1, a BET bromodomain inhibitor, may influence transcription and, consequently, splicing factor activity, potentially impacting SRp55.